Delivery Order SPE2DB24D2101-SPE2DB25FKMTA
- Not listed
- The Defense Logistics Agency awarded a $3,881.47 firm fixed price delivery order to AmerisourceBergen Drug Corp for 40,000 units/mL of Procrit (epoetin alfa), a pharmaceutical used to treat anemia. The award, issued on September 12, 2025, is a non-set-aside competitive contract with an ultimate completion date of September 15, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 10,000 units/mL of Procrit (epoetin alfa), a recombinant erythropoietin used to treat anemia, particularly in military healthcare settings. This firm fixed-price delivery order, valued at $2,296.93, was competitively awarded without a set-aside designation and is scheduled for completion by August 4, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $12,414.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for 10,000 units/mL of Procrit (epoetin alfa), a medication used to treat anemia. The order was placed on September 4, 2025, with an ultimate completion date of September 5, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's qualification to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Procrit 40,000 units/ml vials, a pharmaceutical product used in treating anemia and related conditions. This firm fixed-price delivery order has a ceiling value of $4,092.76 and is scheduled for completion by August 8, 2025. The contract is not set-aside and represents a competitive award to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $18,671.66 to AmerisourceBergen Drug Corp for 10,000 units/mL of Procrit, a pharmaceutical product used to treat anemia. The contract is a firm fixed price delivery order with an ultimate completion date of September 10, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Procrit 10,000 units/ml vials valued at $5,089.52. This firm fixed-price delivery order is set to be completed by October 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside, competitively awarded contract, reflecting AmerisourceBergen's capability to meet federal pharmaceutical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $4,030.22 contract is to supply 40,000 units/mL of the drug Procrit. The delivery order has a completion date of March 22, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,974.94 firm fixed price delivery order is for the supply of 40,000 units/mL of Procrit, a specialty medication. The contract has a completion date of November 24, 2023 and was awarded on November 22, 2023. This award appears to be a task order under a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,609.34 firm fixed-price delivery order is for the supply of 40,000 units/mL of the pharmaceutical product PROCRIT. The contract has an ultimate completion date of April 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,144.26 firm-fixed-price contract is for the supply of 40,000 units/mL of the pharmaceutical product PROCRIT. The contract has an ultimate completion date of August 9, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to various government agencies, including the DLA and the Department of...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMTADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 40,000 units/mL of Procrit (epoetin alfa) with a ceiling value of $11,048.29. The contract was awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, and utilized firm fixed pricing with no set-aside designation. Performance will occur at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp regularly fulfills delivery orders for specialized medications and medical supplies supporting military and veteran healthcare systems. Procrit, a recombinant human erythropoietin used to treat anemia in various medical conditions, represents the type of specialty pharmaceutical product the company supplies through its DLA contracts. The competitively awarded IDC structure enables AmerisourceBergen to efficiently deliver diverse pharmaceutical commodities—including brand-name and generic drugs, vaccines, and medical supplies—to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 7/24/25 |